Remimazolam sedation in ICU patients on mechanical ventilation
Official title: Effect of Remimazolam Sedation on Outcomes of Mechanically Ventilated Patients in the ICU
Run by Southeast University, China · NCT07596589 · Data updated 2026-11-12
This study tests whether using remimazolam for sedation helps mechanically ventilated ICU patients recover better compared to another sedative.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | Southeast University, China Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Status | Recruiting |
| Started | April 1, 2025 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | May 19, 2026 |
| Trial ID | NCT07596589 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who are endotracheally intubated and mechanically ventilated for 24–96 hours and require continued ventilation and sedation for at least 24 hours, with consent provided by family.
✕Probably not a fit
Patients who do not respond to remimazolam or who meet exclusion criteria may not experience a benefit and could experience sedation-related adverse events.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective, randomized controlled pilot study in ICU patients who require mechanical ventilation and sedation. Participants will be assigned to receive remimazolam or an alternative sedative (such as propofol) to reach a target RASS between 0 and -3. The goal is to observe effects on outcomes relevant to ventilation and recovery, with safety and tolerability monitored throughout the course of sedation and withdrawal. The trial aims to generate preliminary data to inform larger studies on sedation strategies in this population.
Why it matters
Potential benefit: If successful, remimazolam could offer effective sedation with favorable recovery and safety profiles for mechanically ventilated ICU patients.
How similar studies have gone: Previous sedative comparisons in ICU settings have shown variability; as a pilot, this study explores a relatively novel use of remimazolam in this context.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years; * Endotracheal intubation and mechanical ventilation for 24-96 hours before enrollment Expected need for continued invasive ventilation and sedation for at least 24 hours; * Target sedation depth on the Richmond Agitation-Sedation Scale (RASS) between 0 and -3; * Informed consent obtained from the patient's family Exclusion Criteria: * Body mass index (BMI) \> 30 kg/m² * Severe central nervous system disease (e.g., acute stroke, uncontrolled seizures, or severe dementia) or any other condition that precludes RASS assessment * Mean arterial pressure (MAP) \< 55 mmHg despite intravenous fluid resuscitation and vasopressors * Heart rate \< 50 beats per minute, or second-degree or third-degree atrioventricular block in the absence of a pacemaker * Acute myocardial infarction or severe heart failure (New York Heart Association \[NYHA\] class IV) * Left ventricular ejection fraction \< 30% * Any contraindication or allergy to benzodiazepines * Substance dependence, alcohol abuse, or psychiatric/psychological disorders. Alcohol abuse was defined as regular consumption of \> 14 drinks per week (1 drink = 150 mL wine, 360 mL beer, or 45 mL liquor) * Acute hepatitis or severe hepatic dysfunction (Child-Pugh class C) * Chronic kidney disease with a glomerular filtration rate (GFR) \< 60 mL/min/1.73 m² * Neuromuscular disease * Patients on extracorporeal membrane oxygenation (ECMO) * Pregnancy or breastfeeding
Where it's running
-
Zhongda Hospital
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Jingyuan Xu, M.D.
- Email: xujingyuanmail@163.com
- Phone: 00862583262500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Perioperative risks in adults with Brugada syndrome during anesthesia and related procedures
This registry follows adults with Brugada syndrome to see how often dangerous heart rhythms occur around anesthesia and up to 30 days after.
-
Neonatal Neurological Observation With Video AI
This study tests a real-time, non-contact video AI system to help monitor brain health in newborns with suspected brain injury during their hospital stay.
-
Inspiring Weaning: Using Breathing Muscle Training in ICU Patients
This trial tests whether inspiratory muscle training helps ICU patients on mechanical ventilation wean off ventilation more quickly.
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
Light exposure during general anesthesia
This test checks whether covering patients' eyes during general anesthesia changes how much anesthetic adults (18–65) need.
-
Comparing two propofol dosing models for sedated ICU patients on ventilators
This study will test whether the Eleveld or Schnider dosing model gives steadier propofol sedation for adults on mechanical ventilation in the ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.